Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hefei Tianhui Investment Group
Hefei, Anhui, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Hefei Tianhui Biotech develops and manufactures recombinant human insulin, insulin analogues, GLP-1 receptor agonists and oral insulin capsules; its partner-reported Phase III oral insulin trial in China has completed with a new drug application submitted to the National Medical Products Administration, with marketing approval pending, while oral insulin capsules have completed a Phase IIb trial in the US and are preparing for a Phase III international multi-center trial in China.[3][2]
- Therapeutic areas
- Endocrinology
- Modalities
- BiologicProteinHormone
- Industry
- Biotech
02
Partnerships
Oramed Pharmaceuticals (licenses and co-develops ORMD-0801 oral insulin, POD Protein Oral Delivery technology, regional commercialization rights in China, Hong Kong and Macau, and multiple joint venture initiatives including the planned OraTech Pharmaceuticals Inc. JV)[9][8][10][12][2]Oravax Medical (historical JV relationship via Oramed for oral COVID-19 vaccine development, leveraging oral delivery technology)[2]Sinopharm Group (partial owner of HTIT and strategic partner in insulin production and commercialization in China)[9]
Beyond the preview
Go deeper on Hefei Tianhui Investment Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hefei Tianhui Investment Group.